Therapeutic Drug Monitoring, Population Pharmacokinetics Models, and External Validation of High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia

External models should be accurately evaluated before they are implemented in clinical practice, even when patients share very similar characteristics.